stockrowTactile Systems Technology, Inc.
TCMD Healthcare Medical Devices
Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024.
- Revenue
- +7.12%
- EPS
- −14.5%
- Free cash flow
- +23.8%
Quarter to September 2026, against a year earlier
Follow TCMD
Alert me
Tactile Systems Technology, Inc. (TCMD) EV/Sales
As of 5 November 2026, Tactile Systems Technology, Inc. (TCMD) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.4× (July 2016) to 10.1× (September 2018); the current reading is higher than 39% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.8× | 61.04% |
| FY2024 | 1.1× | 9.22% |
| FY2023 | 1.0× | 1.55% |
| FY2022 | 1.0× | (46.39%) |
| FY2021 | 1.9× | (58.15%) |
| FY2020 | 4.4× | (32.14%) |
| FY2019 | 6.5× | 19.65% |
| FY2018 | 5.5× | 27.21% |
| FY2017 | 4.3× | 269.66% |
| FY2016 | 1.2× | 167.52% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.2× | (29.97%) |
| Jun 2026 | 1.7× | 15.22% |
| Mar 2026 | 1.5× | (14.68%) |
| Dec 2025 | 1.8× | 121.68% |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| VREX VAREX IMAGING compare | 1.2× |
| TCMD Tactile Systems Technology, Inc. | 1.5× |
| CERS Cerus Corporation compare | 1.7× |
| CTKB Cytek Biosciences, Inc. compare | 2.2× |
| DCTH Delcath Systems, Inc. compare | 4.5× |
| SGHT Sight Sciences, Inc. compare | 5.6× |
| PACB Pacific Biosciences of California, Inc. compare | 7.5× |
| SENS Senseonics Holdings, Inc. compare | 8.3× |
| AVR Anteris Technologies Global Corp. compare | 128× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)